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In principle, the distribution of absorbed
energy in the tissues of a human exposed to ioniz-
ing radiation can either be measured more or less
directly by in situ dosimetry, or it can be cal-
culated from a knowledge of the energies and
angular distributions of the particle fluences
impinging on the individual or phantom. The
first method can quickly and simply determine the
quantity of interest: dose, without the inter-
vening complications, approximations and uncer-
tainties of the second method. In fact, one rea-
son the quantity "dose" was invented was just the
elimination of these intermediate steps. But
direct measurement is not always possible, and it
can seldom be used to obtain dose values at more
than a few points within the tissues. The second,
more indirect method is now developed to a degree
of detail sufficient to produce a virtually com-
plete description of the dose distribution re-
sulting from any arbitrary combination of radia-
tion fluence and energy. Conversion to dose by
calculation, however, not only requires charged
particle telescope or spectrometer data, but a
computer and a program of some complexity as well,
imposing even greater practical limitations than
does the first method.
But a far more fundamental limitation applies
in either case. The use of dosimetric data to
assess the biological implications of a given
exposure requires additional knowledge of the
kinds and degree of effectswhich result, not
simply from the given total amount of absorbed
energy, but much more critically, from the way
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microsopically and macroscopically, in both space
and time, from one case to another. The radio-
biological uncertainties which occur at this
stage are so marked and so incompletely defined
that the ability to establish an exposure status
still clearly lags behind the technical means of
obtaining, by either of the above methods, the
dose data on which to base it.
How then do we arrive at conclusions about
the status of the human individual - which is,
after all, what we are trying to assess - by any
combination of these factors? The question is so
broad and still so debatable that one can only
attempt here to sum up briefly some areas in
which much work has been done in the past, and to
try to illustrate how imprecise are our attempts
to evaluate whole body exposure, as distinct from
the highly local doses so well discussed by Dr.
Curtis. To paraphrase Dr. Drew, we are indeed
trying here to make our technology of physical
measurement serve the cause of human values -
numerical ones, to be sure, but none the less
human - and it is no easier here than it is
elsewhere.
In Fig. i the familiar regulations referring
to ordinary exposures are summarized; in regard
to space radiation exposure they belong to an
earlier and simpler age. Nevertheless, there
are several assumptions implicit in these values
which underlie their apparent simplicity. For
example, quality factors are built in; they are
not mentioned, but a QF is inherent in each rem
unit used. How to decide what these QF's shall
be is of course left up to the technician who
must hold the personnel exposures within these
levels.
More importantly perhaps, the approach used
in setting these regulations is that of the criti-
cal organ or group of organs. The body is sub-
divided into regions or systems, and to a great
extent they are treated separately. This is due
not only to the kind of data available but also
as much as anything else to the necessity of de-
signing regulations which can handle both internal
and external exposures. When radioisotopes are
taken up by the body, of course many of them tend
to concentrate in certain organs; but when an
exposure is external the nonuniformity of dose
distribution occurs for entirely different reasons.
In the case of space radiation exposure this
nonuniformity can reach an extreme degree, not
only with respect to dose distribution and LET but
even to the extent of microscopically localized
high doses of the kind Dr. Curtis has just dis-
cussed. In attempting to deal with such exposures
we are used to a certain kind of thinking, and
although we do not follow it expllcitly in setting
astronaut doses we still tend to think in terms of
critical organs, which may not necessarily be the
best approach in all cases. When we know that an
effect is local, confined to the retina of the
eye for example, we can certainly use this ap-
proach; but if we think that a number or set of
numbers must be sought to describe the overall
physiological status of an individual post-expo-
sure, the critical organ approach can lead to
contradictions.
Fig. 2 sets forth the other half of this
somewhat simplistic approach, Which has still
been found to be practical enough for most cases.
We simply make another set of rules: depending
on the LET of the radiation involved, regardless
of its type, we now multiply any dose by a number,
the QF, and so arrive at its relative "effective-
ness". This can presumably be done for any tissue
location and volume in which this radiation is
deposited, and doses to different regions of the
body are thus multiplied by the appropriate QF's
and treated almost independently.
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Ezposrd Part of Body Occupationally Exposed Persons Public at Large
Whole body, blood- 5 rems/yr 0.5 rems/yr
forming organs and 3 reins/quarter*, provided the
gonads cumulated dose to age N years is
less than 5 (N-18)
30 rems/yr
15 rents :qu.trter
7.; rem_/yr
t0 rem_/quarter
15 rems/'yr
g rent_/qllarter
Bone, thyroid, skin 3 rems/yrt
llands, forearms, feet 7 5 rems/yr
and ankles
All other organs 1.5 rems/yr
* A planned special expo,,ure for ,weupationally exposed workers of twiee the yearly dose is per-
mitred _hen alternative technique_ are either unavailahh" or impractical. This is i0 rems/exposur,'
to the _hole body.
1" 1.5 reins/yr to children tilt to 16.
FIGURE 1
LET®
(keV/g IN WATER) QF
X rays and electrons of any LET 1
3.5 or less 1
3.5-7 1-2
7-23 2-5
23-53 5-10
53-175 10-20
aFromNcRP [1954].
FIGURE 2
In practice, most records that are kept today
are not broken down into these categories. Gener-
ally one is fortunate when one has a single number
to describe a person's exposure. In space, we
are trying to refine things somewhat further
because of the different radiations and higher
doses with which we are concerned, and it is here
that we encounter difficulties in attempting to
apply sets of numbers. The characteristics of
space radiation which are of chief importance in
this regard are the range of energies which occur
and the change of both energy and fluence rate
with time. Dr. Lushbaugh has discussed the
effects of time very thoroughly; some of the other
properties will be mentioned here. The situation
is indeed far more complex than are those for
which the ordinary MPD concepts were developed.
Fig. 3 shows what is perhaps one of the most
important characteristics of heavy particle inter-
actions; the "transition curve" and the build-up
of dose to a maximum due to production of secon-
dary radiations (I). The phenomenon has been
known for some time; its effect on dose distri-
butions is much greater than that of the Bragg
Peak doses at the ends of the paths of charged
particles. The transition build-up results from
the production of secondary particles from two
main processes: intranuclear cascades and
evaporation processes, each of which vary as a
function of both incident particle energy and the
mass number of the target material.
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Fig. 4 illustrates one instance in which a
program was designed to compute dose build-up due
to these secondary processes (2). The experi-
mental data fits the calculated values fairly well
for a beam of the energy indicated (3). Fig. 5
is from another more recent program which con-
verts flux to dose at given energies (4). These
are both representative instances of the kinds of
calculations that are possible. When one also
folds in the energy spectrum of a solar flare,
of trapped radiation, or of galactic cosmic ray
charged particles, the sum of such a set of
curves results in the familiar steep fall-off
of dose with depth.
Quite some time ago, Dr. Schaefer very clear-
ly pointed out that in addition to the distribu-
tion of dose on the macro scale, one should take
into account the high LET at the ends of proton
tracks which result either from neutron inter-
actions or from primary proton cascades or other
secondary processes. At the ends of their
tracks, protons reach about a three-fold higher
value of local LET than do the secondary elec-
trons produced by electromagnetic radiation. All
this is familiar ground; the problem lies in the
distribution and concentration of such track
ends under the conditions we are talking about.
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Fig. 6, from Schaefer, illustrates the dis-
tribution of LET produced by a flux of charged
particles passing through tissue (5). Three
cases are shown; the first is for orthovoltage
250 KVP x-rays, showing the LET distribution of
the secondary electrons produced by the gamma
photons. The second is for a typical solar
flare proton energy spectrum, which produces
essentially the same distribution in LET as do
the x-rays, and should therefore have very much
the same RBE and QF, with the exception of the
small portion of track enders. As Dr. Schaefer
pointed out yesterday, this distribution varies
between earth orbital and free space exposures.
The LET distribution shown in the third case is
that for the recoil protons produced by neutrons
with the fission energy spectrum.
Fig. 7 shows how the use of the QF values
which result from these differing LET distri-
butions were first applied to the calculation of
dose and dose equivalent for tissue for a var-
iety of different energies. This figure, from
Kinney and Zerby (6), shows first the dose and
then the dose equivalent in rem for both nor-
mally incident and isotropically incident proton
fluxes at five centimeters depth in tissue, as a
function of proton energy. Many such curves
have since been generated to estimate how rad and
rem dose should vary with energy at given tissue
depths under a variety of shielding conditions.
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Another way to present the same data is to
calculate separately the dose and dose equi-
valent for each type of secondary particle as a
f_nction of depth so that, for example, normally
incident protons can be treated as producing
ionization from both primary and secondary
protons, secondary neutrons, heavy nuclei, pions,
and so on. All of these sub-classes and their
dose equivalents can then be added together to
give a dose equivalent at any depth.
Fig. 8 shows another way in which such data
have been treated (7). In this figure, the dose
at the center of a water sphere whose radius var-
ies from one centimeter to several tens of cm is
calculated, and a quality factor is also calcu-
lated for its center as a function of the primary
proton energy and hence, of the residual energy
of protons which reach the sphere center. This
quality factor is simply the number of rem per
rad; again, each of the calculated values simply
results in a number by which to multiply a dose
which one may or may not be able to measure
directly.
An _mportant question is:how closely can any
of these numbers be calculated, or applied, to the
quite irregular geometry of the human? Some
heroic efforts to deal with this question are
currently being made. Dr. Kase will talk on this
tomorrow and I will only mention it. Briefly,
coordinate systems are assigned to an average
human geometry, including those body elements
which can be considered as separate systems which
remain internally constant even though their con-
figurations relative to each other change when
seated, standing, and so on.
Using the standard Air Force man, a machine
computation can then produce distributions of
tissue depth surrounding any point in the body,
which will indicate what percent of the total
solid angle subtended by that point is shielded
by a given tissue thickness. In this way the
build-up factors, the attenuation, the production
of secondaries and all of the other physica_ phe-
nomena which intervene between flux and dose can
be treated separately and summed up for the point
in question.
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For example, in Fig. 9 the dose point is the
heart; the curves compare various degrees of de-
tail in such man models and show to what degree
simplification influences the calculated tissue
thickness dl-strlbutlon (8). In a previous study
(9) a given proton spectrum, that measured on a
Gemini mission, was used to determine a dose
conversion factor for several points (e.g., the
center of the gut in Fig. i0); that is, the number
of rads per hour per 104 protons per square cen-
timeter per second. One can say further that for
this particular case, the greatest contribution
to the dose at this particular point in this
particular.standard man is due to the particular
calculated range of incident proton energies
indicated.
What then does physical data of this kind
imply in biological terms? We really do not have
data which is precise enough on the biological
slde (particularly the human biological side, as
Dr. Lushbaugh has pointed out) to match the degree
of detail in the physical data; the kinds of
biological data we do have are Considerably more
"overall" in character. For example, one can
compare experimentally, as Jackson did almost a
decade ago, two types of exposure in which the
familiar depth dose pattern of solar flare pro-
tons is contrasted with an idealized uniform case.
But, in order to do this, he had to do something
physically analogous to what the computational
programs have usually limited themselves to; that
is, he compressed his animals literally into
cylinders, into regular shapes which could be
irradiated with Co-60 ga,,na radiation through a
wedge filter, producing the dose distribution 5y
rotation. It was of course found that the LD-50
dose for a uniform exposure could be described
by a single number, but that for the non-unlform
case, one had to choose some other way of char-
acterizing the dose distribution; for example, the
ratio of midllne to surface dose, or the dose at
some reference depth, e.g., 5 cm.
In Fig. ii, from Dr. Bond and associates at
Brookhaven, another method of comparing different
dose distributions is illustrated (i0). Bilateral
and unilateral exposure data were obtained for
the dog, and the LD-50 dose for 30-day mortality
was expressed as a midline air dose, as a midline
tissue dose, and as an entrance and an exit dose.
Since the bilateral exposure produces a symme-
trical pattern with a build-up in the center, the
midline LD-50 dose is 280 rads, whereas the doses
at entrance and exit are somewhat less; but it is
still almost a flat dose pattern. These values
do not mean a compressed dog, or a cylinder, or
rotation, or anything of the sort; they are sim-
ply data that were already on hand. If one now
considers the unilateral case, with a mldllne
air dose of 384 radsp it takes 337 rads at the
mldllne, with 530 rads at entry and i68 fads at
exit, to produce the same LD-50 in 30 days.
In order to arrive at some way of character-
izing numerically such a difference in uniformity
(Fig. 12) one very roughly divides the body into
three equal regions, each containing part of the
total pool of stem cells which are located in the
marrow and produce the formed elements of the
blood. An estimate is then made of the fraction
of the total stem cell pool which is in the volume
nearest to the Source, the fraction located med-
ially, and the fraction which is in the distal
region. If one then estimates the average dose
to each of these three parts, one can now apply
the known reproductive survival curves for stem
cells, making the as_umptlon, which seems to be
Justified, that they are applicable ID_.V._. If
one then calculates the fraction of each of these
three parts of the marrow cell population which
would be expected to go on proliferating after its
respective dose, and multiplies that part of the
0_oi popul@tlon by its calculated fractional sur-
val, then one can estimate the total relative
number of surviving stem cells; this is shown in
the last column. If one does th_ same thing for
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the bilateral case, which is much more uniform,
one can work backwards from the dose (although
as Dr. Lushhaugh says, "its in a way circular")
and it can be seen that approximately the same
fractional number of survlving_dividing cells
results whether the exposure is uniform or not.
This analysis applies only to a regenerating
tissue; in the case of a tissue which is not pro-
liferating, of course, a different set of con-
siderations apply. Dr. Curtis has pointed out
how the Fractional Cell Lethality concept, a
similar procedure applied to cells surviving
high, localized particle track doses in an organ
which is not proliferating, serves a somewhat
430
similar purpose.
Figs. ii and 12 illustrate an attempt to
normalize and compare whole animal doses, and to
use something similar to an FCL for the whole
exposed mass of proliferating tissue (here, of
cdurse, for radiation of QF i). As a result of
this analysis, an effectiveness factor can be
estimated for the non-uniform distribution com-
pared to the uniform one; the ratio turns out to
be about 0.78 in this case. In this way, a non-
uniform dose distribution can be weighted by a
"Distribution Effectiveness Factor" analogous to
a QF, but now not due to differences in micro
dose distribution, but to dose pattern differences
on the gross level.
I,])_,o(3o) VALUES FOR ])OGS AND SWINE '_.xPOSED BILATERALLY VERSUS UNILATERALLY
TO MEGAVOLTAGE X-RADIATION
Species, exposure type
LD6o(8o)
Midline, .Entrance, Midline, Exit,
air tissue tissue tissue
l)og, bilateral 319 • 266 b 280 b 266 b
I)og, unilateral 384" 530 b 337 b 168 b
_wine, bilateral 3751 272" 234 _ 272"
(350-400) (253-290) (218-250) (253-290)
,qwine, unilateral 500" 584 _ 312 • 131"
:' Exposure in roentgens.
t, Absorbed dose in rads.
FIGURE Ii
CALCULATION OF THE SURVIVING FRACTION OF STEM CELLS IN THE Doa EXPOSED
UNILATERALLY TO 1000-KVP X-RADIATION
Relative n.mber
Body region Dose (fads) Relative number Surviving (%) of sur',q",,ing
of stem cells (from Fig. 1) stem cells
Proximal third 530 43 0.5 0.0
Middle third 337 31 4 1.2
Distal third 168 26 23 6.0
Total 100 7.2
FIGURE 12
In Dr. Lushbaugh's discussion it was shown
that if one attempts to do something similar with
man, one cannot extrapolate from all the animal
data, and one cannot of course do the same kind
of studies on man. But at least, for ordinary
gamma radiations such as from Co-60 and Cs-137,
determining a distribution of the same kind and
making some assumptions based on the known per-
centages of the total marrow which lle at dif-
ferent depths, one can in principle arrive at a
similar distribution effectiveness factor and
compare this for cases in which, accidentally or
otherwise, such non-uniform exposures have been
received. There has been a fair degree of
success in doing this so far. It is clearly
a totally different process than Just multiplying
a dose distribution b_ a QF value, although it
ideally should result in at least an equal degree
of prediction confidence.
As Dr. Curtis has already shown, if one con-
siders radiations of higher LET's, the kinds of
survival curves which can be used to predict the
survival of stem cell populations change in their
shape as well as in their slope. It is the ratio
of dose from a curve for x- or gamma radiation to
that for a higher LET radiation for a given level
of effect which defines the relative biological
effectiveness on which all the QF's are based.
There is a "multievent" shoulder on the low LET
curve; as first shown by Elkind, if one divides
the dose into fractions separated by a time in-
terval long enough for recovery, by the next
time a dose is given the same shoulder has re-
appeared. The increase in dose necessary to give
the same degree of effect when a low LET dose is
protracted can be explained on this basis. In
the case of the straight exponential survival
curve seen for high LET radiation, there is little
or no recovery. The time factor is thus appli-
cable to low LET, but not'signiflcantly to high
LET exposure, Just as the oxygen enhancement ratio
that Dr. Curtis has mentioned also differs for
high and low LET.
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Anotherconsequenceof thefact that the low
LETcurvehasa shoulderandthehighLETonedoesnot is thatthe ratio "RBE"is a functionof
thedegreeof effect. Onethereforehasa range
of RBEvaluesfor anytworadiations,depending
uponhowfar downthepair of survivalcurves
oneis comparingdoses.Forlowdoserate levels
or for manysmalldosesoneis thereforecompar-
ing effectivenessat a different ratio. This
generallyleadsto higherRBEvaluesat lowdoses
thanhaveusuallybeenobtainedexperimentally,
whereit is mucheasierto doanexperimentby
irradiating withhigherdoses.Cautionin theuse
of QF'sis thusnecessarybecauseof this timefactor aswell.
Reliablecollectionsof animaldatanowexist
for reasonablymonoenergeticprimaryneutronexpo-
sures. Theproductionof recoil protonsin thetissuesof rathersmallanimalsresultsin a
fairly predictablemeanLETfor eachof a series
of energies.Experimentsat theseenergiesby
severaldifferentgroupsof investigatorsusing
a numberof endpointshaveproducedRBEvalues
whichfollowa reasonablydefinite relation toLET. This"wholeanimalRBE"is the combined
result of a numberof thingshappeningtogether,
andit doesnotagreeverycloselywith theRBE
fromcell survivalcurves,althoughawholebody
RBEis clearly theendresult of theprocesses
that a single cell survival curve depicts for each
cell type. For these small animals, one gets
RBE's in the range of 5 or 6; if the animal is
larger and the distribution of secondaries is
different, different neutron RBE values may result.
Dr. Lushbaugh has derived a total body RBE
for the human in a mixed field of gamma and neu-
tron radiation by using Hiroshima and Nagasaki
data and comparing the 60-day survival curves
(ii). As shown in Fig. 13, they can be superim-
posed as a function of horizontal range for light
steel buildings, for which the most recent (T-65)
dose estimates of gamma and neutron radiation
yield approximately equal gamma and neutron doses
in Hiroshima, but neutron to gamma ratios of
about i to 12 in Nagasaki. Under these shielding
conditions, he could then try different RBE
factors for the neutron component to make the 50%
survival doses match one another; in this way a
human total body RBE of 2 was estimated. This
should be compared with the value which he dis-
cussed earlier today, which may be about twice
as high when estimated differently and with
better data.
Obviously, the RBE may also depend on how one
chooses the endpoint, and how confident one is
that other factors are not involved, such as blast
and burn damage in the case of the Japanese. One
clearly cannot be as exact or as confident with
the human data as is possible with "cells, or
even with small animal data. This is one reason
the total body, approximate but presumably over-
cautious QF values were invented, to be distin-
guished from RBE's. It also should illustrate
the logical inconsistency of multiplying the dose
at each point in a distribution by such QF values,
a practice which has unfortunately become rather
widespread.
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Fig. 14 summarizes the situation that obtains
if one varies yet another parameter, the area of
field in a skin exposure (12). This is a col-
lection of data from radiotherapy which shows
skin tolerance in roentgens as a function not
only of the number of fractions into which a
given dose is divided, but also how big an area
of skin is irradiated. It can be seen that
there is an area _actor as well as a time factor.
The 2000 tad figure for a single dose that is
listed, for example, in the NAS-NRC Space Radia-
tion Study Panel Report (13) is also seen here;
but fractionating the dose raises it, increasing
the area lowers it, and so forth.
In summary, it can be seen that we are able
by various combinations of numbers and factors to
arrive at estimates of dose and dose effective-
ness from values of fluence; but as yet it has not
been possible to use the biological data with the
same degree of precision with which one can obtain
or estimate the physical data. Certainly, a QF,
even properly used, is by no means the only modi-
fying factor that one must apply to a flux-to-dose
conversion; the distribution factor and the time
factor are there to contend with, and the area
factor as well. But above all, one must at least
consider the possibility of treating a total
exposure not simply on the basis of a collection
of separate organs wired together, each with its
own sensitivity, but by applying a separate organ
approach only very judiciously as a part of the
characterization of a total body exposure. It
would seem that the most reasonable way one can
use the human data that exists is to apply it as
far as possible to the human animal as a whole,f4).
To conclude: the particular dosimetric problems
of the space environment have been a stimulus to
such efforts - but the results can clearly be
useful in terrestrial human affairs.
6000--
5500
- sooo _.I
,_ 4000
c
o
3500
o
.E 3000
2500
2000
1500
\
\
\
--..,
I00
4 days
Idoys
200 300
Area of field cm z
_" 2 weeks IClt reatments
8 days
5weeks 25_e_
FIGURE 14
5weeks _5tre_menls
4OO 5OO 6O0
433
1.
2.
3.
4.
5.
6.
7.
8.
9.
i0.
ii.
12.
13.
REFERENCES
Shen, S. P. (1963). Nuclear problems in
radiation shielding in space. Astronaut
Acta 9, 211.
Wallace, R. W., Steward, P. G. and Sondhaus,
C. A. (1964). Primary and secondary
proton dose rates in spheres and slabs
of tissue. Proc. 2nd Symp. Prot. Against
Radiations in Space, Gatlinburg, 1964
NASA-SP-71, p. 301.
Tanner, R. L., Baily, N. A. and Hilbert, J.
W. (1967). High energy proton depth dose
patterns. Radiation Res. 12, 861.
Alsmiller, R. G., Armstrong, T. W. and
Coleman, W. A. (1970). The absorbed
dose and dose equivalent from neutrons
in the energy range 60 to 3000 MeV and
protons in the energy range 400 to 3000
MeV. Oak Ridge Natl. Lab. Report ORNL-
TM-2924 (Rev).
Schaefer, R. J. (1964). Local LET spectra
in tissue for solar flare protons in
space and for neutron-produced recoil
protons. Symp. Biol. Effects Neutron
Proton Irrad., Upton, N. Y. 1963, Vol. I,
p. 297. IAEA, Vienna.
Kinney, W. E. and Zerby, C. D. (1964).
Calculated tissue current-to-dose cQn-
version factors for nucleons of energy
below 400 MeV. Proc. 2nd Symp. Prot.
Against Radiations in Space, Gatlinburg,
1964 NASA-SP-71_ p. 171.
Madey, R. and Stephenson, T. E. (1964),
Quality factors for degraded proton spec-
tra. Proc. 2nd Symp. Prot. Against
Radiations in Space, Gatlinburg, 1964
NASA-SP-71, p. 229.
Kase, P. G. (1971). This symposium, Paper
VII.4.5.
Holly, F. E. Private communication.
Bond, V. P. and Robinson, C. V. (1967). A
mortality determinant in nonuniform expo-
sures of the mammal. Radiation Res.
Suppl. 7, 265.
Lushbaugh, C. C. (1969). Reflections on some
recent progress in human radiobiology.
In "Advances in Radiation Biology", Vol.
3 (L. G. Augenstein, R. Mason and M. Zelle,
editors), p. 277.
Paterson, R. (1948). "The Treatment of
Malignant Disease by Radium and X-rays",
Arnold, London.
NAS-NRC (1967). "Radiobiological Factors in
Manned Space Flight", Report of the Space
Radiation Study Panel. (W. H. Langham,
editor). Nat'l Acad. Soi.-Nat'l Res.
Council, Space Sci. Board, Washington,
D.C.
14. Sondhaus, C. A. and Evans, R. D. (1969).
Dosimetry of radiation in space flight.
In "Radiation Dosimetry", 2nd ed., Vol.
III (F. H. Affix, W. E. Roesch and E.
Tochilin, eds.), Chapter 26, p. 453.
Academic Press, New York.
434
